» Articles » PMID: 10435150

Multiple Primary Tumours in Patients with Oral Squamous Cell Carcinoma

Overview
Journal Oral Oncol
Publisher Elsevier
Specialty Dentistry
Date 1999 Aug 6
PMID 10435150
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

A series of patients with oral squamous cell carcinoma (SCC) observed at the "Regina Elena" Cancer Institute was retrospectively reviewed in order to analyse the risk factors for multiple and second primary tumours (SPTs), their impact on survival and effective measures to control this phenomenon. In a survey of 200 individuals with a median follow-up of 3.2 years (25th percentile: 1.2, 75th percentile: 5.5), the incidence rate of SPTs was 14%: 39% arose in the oral cavity, 18% in the oropharynx, 10% in the lung and 7% both in the lip and larynx. There were no cases of secondary oesophageal tumours. Ninety-six per cent of the diagnosed histological types of SPTs were SCCs. Forty per cent of the new cancers were synchronous and 60% were metachronous, developing at a steady rate of 1.5% per year with no evidence of plateau. The overall incidence, adjusted by the length of follow-up, was 40 SPTs per 1000 person-years of follow-up. Although all the patients were at a greater risk for SPTs, the rates widely varied, according to specific factors: heavy tobacco consumption accounted for a statistically significant risk excess which was particularly high among younger smokers with an index tumour of the lower oral cavity. No difference was noticed in relation to the index neoplasm stage. In patients both with localised and advanced index tumours, 5-year survival rates were lower in those with SPTs and the difference was statistically significant for the 2-year survivors who were most likely to overcome the first disease. The present study confirms, the exceptionally high incidence of multifocal SCC in oral cancer patients and emphasizes the importance of preventive measures, since careful screening procedures, carried out to detect multifocal tumours at an early stage, should improve survival in these patients.

Citing Articles

Development of morphologically diverse benign neoplasms preceding metachronous oral squamous cell carcinoma: A rare case report.

Padhiary S, Srivastava G, Panda S, Mohanty N Natl J Maxillofac Surg. 2025; 15(3):521-525.

PMID: 39830462 PMC: 11737561. DOI: 10.4103/njms.njms_135_23.


Oral squamous cell carcinoma in the Sudan: clinical behavior, DNA ploidy and S-phase fraction characteristics.

Eltohami Y, Eltayeb O, Suleiman A BMC Oral Health. 2024; 24(1):1473.

PMID: 39633352 PMC: 11619201. DOI: 10.1186/s12903-024-05270-x.


Survival analysis of Sudanese oral squamous cell carcinoma patients with field of cancerization.

Eltohami Y, Suleiman A BMC Cancer. 2024; 24(1):473.

PMID: 38622532 PMC: 11017610. DOI: 10.1186/s12885-024-12197-7.


Proliferative verrucous leukoplakia: a case report of multiple metachronous oral verrucous carcinoma.

Lombardi N, Varoni E, Franchini R, Lodi G BMJ Case Rep. 2023; 16(11).

PMID: 37967933 PMC: 10660804. DOI: 10.1136/bcr-2023-256383.


Efficacy of concurrent chemoradiotherapy with retrograde super selective intra-arterial infusion combined with cetuximab for synchronous multifocal oral squamous cell carcinomas.

Chen X, Kioi M, Hayashi Y, Koizumi T, Koike I, Yamanaka S Radiat Oncol. 2023; 18(1):90.

PMID: 37237293 PMC: 10224585. DOI: 10.1186/s13014-023-02282-9.